Superior HealthPlan Marks 25th Anniversary with $25,000 Grant to NAMI El Paso
Superior HealthPlan Marks 25th Anniversary with $25,000 Grant to NAMI El Paso Superior HealthPlan, a prominent managed care organization in Texas and a subsidiary of Centene Corporation (NYSE: CNC), announced a $25,000 grant to National Alliance on Mental Illness (NAMI)…
HCA Healthcare Appoints Wendy Warren as SVP & Chief Ethics Officer
HCA Healthcare Appoints Wendy Warren as SVP & Chief Ethics Officer HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, has announced the appointment of Wendy Warren as senior vice president and chief ethics and compliance officer,…
Opdivo Qvantig™ FDA Approved for Subcutaneous Use in Adult Solid Tumor Indications
Opdivo Qvantig™ FDA Approved for Subcutaneous Use in Adult Solid Tumor Indications Bristol Myers Squibb (NYSE: BMY) recently announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) injection for subcutaneous use. This combination…
Gastric Cancer: TEVIMBRA Approved in U.S. for First-Line Treatment
Gastric Cancer: TEVIMBRA Approved in U.S. for First-Line Treatment BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company set to change its name to BeOne Medicines Ltd., today announced that the U.S. Food and Drug Administration (FDA)…
Takeda Announces HYQVIA® 10% Injection Approval in Japan for Agammaglobulinemia
Takeda Announces HYQVIA® 10% Injection Approval in Japan for Agammaglobulinemia Takeda (TSE:4502/NYSE:TAK) has announced that the Japanese Ministry of Health, Labour and Welfare has approved HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] for the treatment of patients…
Kerecis Expands Silicone Fish-Skin Line with SurgiClose®
Kerecis Expands Silicone Fish-Skin Line with SurgiClose® Kerecis, a leader in the use of sustainably sourced fish skin and fatty acids for cellular therapy, tissue regeneration, and protection, has announced the launch of SurgiClose® Silicone. This innovative product combines fish-skin…
Wearables to Be Used by 50% of Older Adults for Life-Saving Alerts by 2034, Predicts ScienceSoft
Wearables to Be Used by 50% of Older Adults for Life-Saving Alerts by 2034, Predicts ScienceSoft ScienceSoft has released a comprehensive report examining the future of wearables in preventive healthcare for older adults. The study, supported by data from statistical…
Tivic Health CEO’s Letter to Shareholders
Tivic Health CEO’s Letter to Shareholders Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company pioneering bioelectronic medicine, has released its annual letter from the CEO to shareholders, highlighting key milestones in 2024 and setting the stage for exciting…
Sensorion Completes Enrollment of First Cohort in Audiogene Phase 1/2 Trial
Sensorion Completes Enrollment of First Cohort in Audiogene Phase 1/2 Trial Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company focused on developing innovative therapies for hearing loss disorders, has successfully completed patient enrollment for the first cohort in its…
Digital Health Tools Expanding to Support Patient Care, Reports IQVIA
Digital Health Tools Expanding to Support Patient Care, Reports IQVIA Despite a decline in venture funding for digital health companies over the past two and a half years, digital health products and solutions are rapidly evolving to enhance patient diagnosis,…
Investor Consortium and NEA to Take NeueHealth Private
Investor Consortium and NEA to Take NeueHealth Private Investor Consortium, led by New Enterprise Associates (NEA), has announced that it has entered into a definitive merger agreement to acquire NeueHealth, Inc. (NYSE: NEUE), a value-driven healthcare company, for approximately $1.3…
Anebulo Pharmaceuticals announces positive update and capital raise for Selonabant
Anebulo Pharmaceuticals announces positive update and capital raise for Selonabant Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company focused on developing innovative treatments for acute cannabinoid-induced toxicities, has announced a positive regulatory update and the successful completion of a…